Rovida Advisors Inc. Bausch Health Companies Inc. Transaction History

Rovida Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $4.98 Million - $6.86 Million	-325,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$13.31 - $20.51 $4.33 Million - $6.67 Million	325,000 New	325,000 $5.94 Million
Q1 2020 May 13, 2020	SELL	$12.98 - $30.25 $15.4 Million - $35.9 Million	-1,186,576 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$18.89 - $31.89 $17.7 Million - $30 Million	-939,314 Reduced 44.18%	1,186,576 $35.5 Million
Q3 2019 Nov 08, 2019	BUY	$20.88 - $25.66 $44.4 Million - $54.6 Million	2,125,890 New	2,125,890 $46.4 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.77B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Rovida Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Rovida Advisors Inc. with notifications on news.